Evidence map›Paper›PMID 31700799›Full record

ArticleIDCases2019

False resistance after artemether-lumefantrine treatment in a falciparum malaria patient in Turkey: A case report.

Ozgur Koru, Ertugrul Yazici, Charlotte Rasmussen, Pascal Ringwald, Cumhur Artuk, Orhan Bedir

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IDCases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ozgur KoruGulhane Training and Research Hospital, Department of Medical Microbiology, Etlik, Ankara, Turkey.
Ertugrul YaziciWorld Health Organization, 20 Avenue Appia, 1211, Geneva 27, Switzerland.
Charlotte RasmussenGulhane Training and Research Hospital, Department of Infectious Diseases, Etlik, Ankara, Turkey.
Pascal RingwaldGulhane Training and Research Hospital, Department of Infectious Diseases, Etlik, Ankara, Turkey.
Cumhur ArtukWorld Health Organization, 20 Avenue Appia, 1211, Geneva 27, Switzerland.
Orhan BedirGulhane Training and Research Hospital, Department of Medical Microbiology, Etlik, Ankara, Turkey.
Gülhane Askerî Tıp Akademisi · TRWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionArtemisinin-based combination therapy (ACT) is recommended by the World Health Organization as first-line treatment of uncomplicated Plasmodium falciparum malaria. ACT treatments failures among travellers returning from Africa to non-endemic countries are considered to be caused by resistance. CASE PRESENTATION: We report on a case of artemether-lumefantrine treatment failure in a Turkish traveller with uncomplicated

conclusionsInformation on returning travellers, includes ensuring that the patients receive supervised treatment with the recommended dose of a quality controlled medicine, routine follow-up of all cases, assessment of adequate absorption of the drug, and/or testing the prevalence of molecular markers of drug resistance if validated, can be an important source of an early warning system for emerging resistance.

Indexed as

Artemisinin-based combination therapyMalariaP. falciparum

Identifiers

PMID31700799
PMCPMC6831798
OpenAlexW2979921698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.